We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

84 hedge funds and large institutions have $87.5M invested in VanEck Biotech ETF in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

335% more call options, than puts

Call options by funds: $1.9M | Put options by funds: $436K

29% more capital invested

Capital invested by funds: $67.8M → $87.5M (+$19.6M)

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

3.9% more ownership

Funds ownership: 16.34% → 20.24% (+3.9%)

1% more funds holding

Funds holding: 83 → 84 (+1)

46% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 24

Holders
84
Holders Change
+1
Holders Change %
+1.2%
% of All Funds
1.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
24
Closed
8
Calls
$1.9M
Puts
$436K
Net Calls
+$1.46M
Net Calls Change
+$1.59M

Top Buyers

Rank Fund Capital Flow
1
CWM
Cornerstone Wealth Management
Missouri
+$8.99M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.5M
3
VF
Virtu Financial
New York
+$3.59M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.36M
5
Jane Street
Jane Street
New York
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$830K
2
ClearBridge Investments
ClearBridge Investments
New York
-$540K
3
OAM
Occidental Asset Management
California
-$432K
4
TRCT
Tower Research Capital (TRC)
New York
-$422K
5
MCM
Murphy Capital Management
New Jersey
-$412K
Name Holding Trade Value Shares
Change 		Change in
Stake
FANJ
51
Financial Architects (New Jersey)
New Jersey
$214K – – –
LTFS
52
Ladenburg Thalmann Financial Services
Florida
$183K -$102K -783 -37%
EDRH
53
Edmond de Rothschild Holding
Switzerland
$171K +$78K +600 +92%
NSIM
54
North Star Investment Management
Illinois
$161K – – –
CG
55
Cutler Group
California
$145K +$139K +1,071 New
AG
56
Advisor Group
Arizona
$144K -$1.3K -10 -0.9%
Citigroup
57
Citigroup
New York
$130K – – –
William Blair & Company
58
William Blair & Company
Illinois
$122K – – –
KTC
59
Kistler-Tiffany Companies
Pennsylvania
$72K – – –
OGC
60
Oak Grove Capital
New Hampshire
$68K – – –
RAM
61
Riggs Asset Management
Pennsylvania
$43K – – –
Deutsche Bank
62
Deutsche Bank
Germany
$41K – – –
KPCM
63
Kings Point Capital Management
New York
$37K – – –
AF
64
Arrow Financial
New York
$34K – – –
DBT
65
Dubuque Bank & Trust
Iowa
$34K – – –
FHA
66
Flagship Harbor Advisors
Massachusetts
$34K – – –
AIM
67
Anchor Investment Management
South Carolina
$21.1K – – –
HNB
68
Huntington National Bank
Ohio
$21K – – –
GCM
69
Gables Capital Management
Florida
$20K – – –
OSNBOA
70
Old Second National Bank of Aurora
Illinois
$20K – – –
US Bancorp
71
US Bancorp
Minnesota
$20K – – –
RMAM
72
Raab & Moskowitz Asset Management
New Jersey
$18K +$17.4K +134 New
AP
73
Advisors Preferred
Maryland
$18K +$17.9K +138 New
M
74
MOTCO
Texas
$14K – – –
APA
75
American Portfolios Advisors
New York
$13.6K – – –
1 2
3
4

BBH Hedge Fund Activity: Q3 2018 in Review

84 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2018, worth a combined $87.5M — up 29% from $67.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BBH positions and 8 closed out — a net gain of 2 holders — while 13 added to existing stakes and 24 trimmed.

The largest buyer was Cornerstone Wealth Management, opening a new position worth an estimated $8.99M. The largest seller was UBS Group, cutting an estimated $830K.

  • 84 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2018, up from 83 in Q2 2018.
  • Funds reported $87.5M of VanEck Biotech ETF stock for Q3 2018, up 29% quarter-over-quarter.
  • 10 funds opened new VanEck Biotech ETF positions in Q3 2018 and 8 closed out, a net change of +2 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2018 was Cornerstone Wealth Management, an estimated $8.99M added.
  • The largest VanEck Biotech ETF seller in Q3 2018 was UBS Group, an estimated $830K sold.

Based on aggregated 13F filings for Q3 2018.